Literature DB >> 15994677

Use of antiviral drug in poultry is blamed for drug resistant strains of avian flu.

Jane Parry.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15994677      PMCID： PMC558527          DOI： 10.1136/bmj.331.7507.10

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Infections in hemodialysis: a concise review - Part 1: bacteremia and respiratory infections.

Authors:  T Eleftheriadis; V Liakopoulos; K Leivaditis; G Antoniadi; I Stefanidis
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

Review 2.  Pandemism of swine flu and its prospective drug therapy.

Authors:  R K Saxena; P Tripathi; G Rawat
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-16       Impact factor: 3.267

3.  Salinomycin Inhibits Influenza Virus Infection by Disrupting Endosomal Acidification and Viral Matrix Protein 2 Function.

Authors:  Yejin Jang; Jin Soo Shin; Yi-Seul Yoon; Yun Young Go; Hye Won Lee; Oh Seung Kwon; Sehee Park; Man-Seong Park; Meehyein Kim
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

4.  Dryocrassin ABBA, a novel active substance for use against amantadine-resistant H5N1 avian influenza virus.

Authors:  Changbo Ou; Qiang Zhang; Guojiang Wu; Ningning Shi; Cheng He
Journal:  Front Microbiol       Date:  2015-06-16       Impact factor: 5.640

Review 5.  Antiviral Therapeutic Potential of Curcumin: An Update.

Authors:  Abdollah Ardebili; Mohammad Hassan Pouriayevali; Sahar Aleshikh; Marziyeh Zahani; Mehdi Ajorloo; Ahdieh Izanloo; Abolghasem Siyadatpanah; Hadi Razavi Nikoo; Polrat Wilairatana; Henrique Douglas Melo Coutinho
Journal:  Molecules       Date:  2021-11-19       Impact factor: 4.411

Review 6.  Insight into alternative approaches for control of avian influenza in poultry, with emphasis on highly pathogenic H5N1.

Authors:  E M Abdelwhab; Hafez M Hafez
Journal:  Viruses       Date:  2012-11-19       Impact factor: 5.048

Review 7.  Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.

Authors:  Michael G Ison; Frederick G Hayden; Alan J Hay; Larisa V Gubareva; Elena A Govorkova; Emi Takashita; Jennifer L McKimm-Breschkin
Journal:  Antiviral Res       Date:  2021-08-04       Impact factor: 10.103

Review 8.  Next-generation direct-acting influenza therapeutics.

Authors:  Mart Toots; Richard K Plemper
Journal:  Transl Res       Date:  2020-02-04       Impact factor: 7.012

Review 9.  Avian flu: what the otolaryngologist needs to know.

Authors:  Steven K Burkhead; Peter G Michaelson; Eric A Mair
Journal:  Otolaryngol Head Neck Surg       Date:  2006-11       Impact factor: 3.497
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.